Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
2.
Antimicrob Agents Chemother ; 56(5): 2565-9, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22354306

RESUMO

The objective of this study was to identify the oral pathogens found in odontogenic infections, to determine their susceptibilities to amoxicillin-clavulanic acid (AMC), clindamycin (CLI), doxycycline (DOX), levofloxacin (LVX), moxifloxacin (MXF), and penicillin (PEN), and to search for associations between specific pathogens and types of infection. Swabs from patients enrolled in a randomized, double-blind phase II trial comparing MXF with CLI for the treatment of odontogenic abscesses or inflammatory infiltrates were cultured on media for aerobes and anaerobes. All bacterial isolates were identified at the species level. Overall, 205 isolates were cultured from 71 patients: 77 viridans group streptococci, 56 Prevotella spp., 19 Neisseria spp., 17 Streptococcus anginosus group isolates and hemolytic streptococci, 15 other anaerobes, and 21 other bacteria. Ninety-eight percent of pathogens were susceptible to MXF, 96% to AMC, 85% to LVX, 67% to PEN, 60% to CLI, and 50% to DOX. S. anginosus group and hemolytic streptococci were found significantly more frequently (P = 0.04) in patients with abscesses (12/95) than in patients with infiltrates (5/110). In four patients with infiltrates who failed to respond to CLI therapy, three isolates of the Streptococcus mitis group and four Neisseria spp. resistant to CLI were found. In this study, S. anginosus group and hemolytic streptococci were clearly associated with odontogenic abscesses. Our analysis suggests that viridans group streptococci and Neisseria spp. play a decisive role in the etiology of odontogenic infiltrates. The high in vitro activity of MXF against odontogenic bacteria corresponds well to its clinical results in the treatment of odontogenic abscesses and infiltrates.


Assuntos
Compostos Aza/uso terapêutico , Bactérias Aeróbias/efeitos dos fármacos , Bactérias Anaeróbias/efeitos dos fármacos , Infecções Bacterianas/tratamento farmacológico , Clindamicina/uso terapêutico , Abscesso Periodontal/tratamento farmacológico , Quinolinas/uso terapêutico , Combinação Amoxicilina e Clavulanato de Potássio/administração & dosagem , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Compostos Aza/administração & dosagem , Bactérias Aeróbias/crescimento & desenvolvimento , Bactérias Anaeróbias/crescimento & desenvolvimento , Infecções Bacterianas/microbiologia , Clindamicina/administração & dosagem , Meios de Cultura , Método Duplo-Cego , Feminino , Fluoroquinolonas , Alemanha , Humanos , Masculino , Testes de Sensibilidade Microbiana , Moxifloxacina , Pacientes Ambulatoriais , Penicilinas/administração & dosagem , Penicilinas/uso terapêutico , Abscesso Periodontal/microbiologia , Estudos Prospectivos , Quinolinas/administração & dosagem
3.
Br Dent J ; 206(7): 357-62, 2009 Apr 11.
Artigo em Inglês | MEDLINE | ID: mdl-19357666

RESUMO

Antibiotics are the most widely prescribed category of drugs issued on prescription by general dental practitioners. Despite this there remains little evidence-based literature on what should be prescribed for any given clinical situation, at what dosage and for how long. Given the current climate of evidence-based research, the need to keep antibiotic prescribing to an acceptable minimum, increasing levels of resistance of micro-organisms and widespread hospital infections with 'superbugs', there is a distinct need for appropriate prescribing guidelines. Considering best practice, an extensive review of the literature and a thorough understanding of current empirical treatment regimes, an attempt has been made to recommend suitable antibiotic prescribing for the adult patient suffering from acute dentoalveolar infections based on evidence.


Assuntos
Antibacterianos/uso terapêutico , Uso de Medicamentos/normas , Abscesso Periapical/tratamento farmacológico , Abscesso Periodontal/tratamento farmacológico , Doença Aguda , Adulto , Amoxicilina/uso terapêutico , Clindamicina/uso terapêutico , Drenagem , Farmacorresistência Bacteriana , Odontologia Baseada em Evidências , Humanos , Metronidazol/uso terapêutico , Testes de Sensibilidade Microbiana , Penicilina V/uso terapêutico , Abscesso Periapical/microbiologia , Abscesso Periodontal/microbiologia , Guias de Prática Clínica como Assunto
4.
J Craniomaxillofac Surg ; 36(8): 462-7, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18760616

RESUMO

OBJECTIVES: We examined the spectrum of oral pathogens found in odontogenic abscesses and their susceptibility to penicillin as well as to amoxicillin with clavulanic acid, doxycycline, clindamycin and moxifloxacin. The in vitro results were compared with clinical observations. PATIENTS AND METHODS: One hundred and eighty eight swabs were obtained from 94 patients with odontogenic abscesses. Bacterial strains were isolated for susceptibility tests. The same patients were investigated for their clinical outcome after standard therapy. RESULTS: A total of 517 bacterial strains were isolated from 94 patients. Ninety eight per cent of abscesses were polymicrobial. The most prevalent bacteria were Viridans streptococci representing 54% of the aerobic/facultative anaerobic bacteria. Prevotella spp. comprised 53% of the anaerobes. No multiresistant strains were detected. Susceptibility testing revealed a sensitivity of over 99% of aerobes/facultative aerobes and 96% of anaerobes sensitivity for moxifloxacin. The corresponding values for penicillin were lowest at 61% and 79%, respectively. In the clinical collective, patients with minor abscesses and no risk of further progression received surgical treatment without antibiotics (36%). Penicillin was administered additionally in 30%. Amoxicillin with clavulanic acid was given in 18% and clindamycin in 15%. Ninety two of the 94 patients showed significant recovery with the described treatment. Only in two cases was a change to the latest broader spectrum antibiotics necessary. CONCLUSION: In contrast to the moderate in vitro results, penicillin successfully treated the pathogens derived from odontogenic abscess sufficiently when adequate surgical treatment was provided. One third of the patients was treated successfully with incision and drainage only. We suggest that one good reason for its clinical efficacy is the susceptibility of the dominant aerobe/facultative aerobe and anaerobe strains to penicillin.


Assuntos
Antibacterianos/uso terapêutico , Testes de Sensibilidade Microbiana , Penicilinas/uso terapêutico , Abscesso Periodontal/microbiologia , Doença Aguda , Antibacterianos/classificação , Contagem de Colônia Microbiana , Resistência Microbiana a Medicamentos , Humanos , Abscesso Periodontal/complicações , Abscesso Periodontal/tratamento farmacológico , Resultado do Tratamento
5.
Mund Kiefer Gesichtschir ; 9(6): 377-83, 2005 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-16261393

RESUMO

BACKGROUND: The role played by odontogenic infection in dental, oral, and maxillofacial surgery is not to be underestimated even at the present time. An extensive, standardized, prospective study was performed with the intention of verifying the bacterial spectrum of odontogenic infections to evaluate antibiotic sensitivity. MATERIAL AND METHODS: Bacterial spectra and resistograms of 65 patients with an odontogenic infection were analyzed in a prospective study under standardized conditions for specimen collection and transport. RESULTS: A total of 226 bacterial strains were analyzed. The ratio between anaerobes and aerobes was approximately 2:1. The most frequent aerobes were members of the genera Streptococcus (46 isolates), Staphylococcus (10 isolates), and Neisseria (9 isolates), respectively. The anaerobic gram-positive spectrum was dominated by members of the genera Eubacterium (19 isolates), Peptostreptococcus (16 isolates), and Actinomyces (12 isolates). The most frequently isolated gram-negative anaerobes were Prevotella (46 isolates), and Fusobacterium (21 isolates). The overall resistance to antibiotics was very low: only 7.3% of all bacteria were resistant to penicillin G/V, and 8.8% showed resistance to ampicillin. The resistance rates to other beta-lactam antibiotics were 4.4% to piperacillin and 0.6% to imipenem, respectively. Penicillin G presented the highest antimicrobial activity among aerobes: only 4.5% of anaerobic strains were resistant of penicillin G. The other resistance rates of anaerobic bacteria to antibiotics were as follows: ampicillin 24%, doxycycline 34%, erythromycin 18%, and clindamycin 9.3%. Penicillin G was also highly antimicrobially active to anaerobes. The resistance rates were: penicillin G 8.1%, ampicillin 2.6%, doxycycline 9.2%, erythromycin 10.2%, and clindamycin 1.4%, respectively.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Penicilinas/uso terapêutico , Abscesso Periapical/tratamento farmacológico , Abscesso Periodontal/tratamento farmacológico , Adolescente , Adulto , Idoso , Infecções Bacterianas/microbiologia , Criança , Pré-Escolar , Resistência a Múltiplos Medicamentos , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Resistência às Penicilinas , Penicilinas/efeitos adversos , Abscesso Periapical/microbiologia , Abscesso Periodontal/microbiologia , Prevotella intermedia/efeitos dos fármacos , Prevotella nigrescens/efeitos dos fármacos , Estudos Prospectivos
6.
Antimicrob Agents Chemother ; 46(12): 4019-21, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12435716

RESUMO

We evaluated the antimicrobial susceptibility of 87 pathogens isolated from 37 patients with odontogenic abscesses. The most prevalent bacteria were viridans group streptococci and Prevotella species. Considering all bacterial isolates, 100% were susceptible to amoxicillin-clavulanic acid, 98% were susceptible to moxifloxacin and to levofloxacin, 76% were susceptible to doxycycline, 75% were susceptible to clindamycin, and 69% were susceptible to penicillin.


Assuntos
Anti-Infecciosos/uso terapêutico , Compostos Aza , Bactérias/efeitos dos fármacos , Fluoroquinolonas , Abscesso Periodontal/microbiologia , Quinolinas , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Bactérias/isolamento & purificação , Criança , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Moxifloxacina , Abscesso Periodontal/tratamento farmacológico
7.
Artigo em Inglês | MEDLINE | ID: mdl-11077383

RESUMO

OBJECTIVE: The aim of this study was to obtain information for an effective antimicrobial therapy against orofacial odontogenic infections; such information was obtained from recent bacteriologic features and antimicrobial susceptibility data. STUDY DESIGN: The bacteriology and antimicrobial susceptibility of major pathogens in 163 patients with orofacial odontogenic infections to 7 antibiotics was examined. RESULTS: Mixed infection of strict anaerobes with facultative anaerobes (especially viridans streptococci) was observed most often in dentoalveolar infections, periodontitis, and pericoronitis. Penicillin (penicillin G) was effective against almost all pathogens, although it did not work well against beta-lactamase-positive Prevotella. Cefmetazole was effective against all test pathogens. Erythromycin was ineffective against viridans streptococci and most Fusobacterium. Clindamycin exerted a strong antimicrobial activity on anaerobes. Minocycline was effective against almost all the test pathogens. The antimicrobial activity of levofloxacin against viridans streptococci was not strong. CONCLUSIONS: An antibiotic that carries out antimicrobial activity against both viridans streptococci and oral anaerobes should be suitable for treatment of dentoalveolar infection, periodontitis, and pericoronitis. Penicillin remains effective as an antimicrobial against most major pathogens in orofacial odontogenic infections. Cefmetazole, clindamycin, and minocycline may be effective against most pathogens, including penicillin-unsusceptible bacteria.


Assuntos
Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Bactérias Anaeróbias/efeitos dos fármacos , Infecções Bacterianas/microbiologia , Doenças da Boca/microbiologia , Streptococcus/efeitos dos fármacos , Infecções Bacterianas/tratamento farmacológico , Cefmetazol/farmacologia , Distribuição de Qui-Quadrado , Clindamicina/farmacologia , Resistência Microbiana a Medicamentos , Eritromicina/farmacologia , Humanos , Testes de Sensibilidade Microbiana , Minociclina/farmacologia , Doenças da Boca/tratamento farmacológico , Penicilinas/farmacologia , Penicilinas/uso terapêutico , Abscesso Periapical/microbiologia , Pericoronite/microbiologia , Abscesso Periodontal/microbiologia , Periodontite/microbiologia , Prevotella/efeitos dos fármacos , Prevotella/metabolismo , beta-Lactamases/biossíntese
8.
Stomatologiia (Mosk) ; 77(4): 17-9, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9752730

RESUMO

Sensitivities of peptostreptococci, streptococci, Actinomyces, bacteroid, and fusobacterial strains pathogenic for the periodontium to wide-spectrum penicillines, cephalosporines, lincomycin, macrolides, metronidasole, and nitasole are compared. New macrolide antibiotics rulide. Macropene, gramicidin C, levomycetin, and rifampicin are highly effective. Some narrow-spectrum drugs, e.g. augmentin, cephalexin, and vancomycin (towards actinomycetes) were highly effective, too.


Assuntos
Antibacterianos/uso terapêutico , Periodontite/tratamento farmacológico , Doença Aguda , Adolescente , Adulto , Idoso , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Bactérias/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Abscesso Periodontal/tratamento farmacológico , Abscesso Periodontal/microbiologia , Periodontite/microbiologia
9.
J Clin Periodontol ; 21(2): 98-106, 1994 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8144740

RESUMO

The importance of microbial surveillance is illustrated in 3 clinical cases. Each case demonstrated a continued lack of response to conventional periodontal treatment. Repeated bouts of periodontal abscess formation and bone loss occurred over a 3- to 4-year period, despite numerous surgeries supplemented with antibiotics. As a result, patients were termed refractory to treatment and extensive microbiological analysis and sensitivity testing was performed. Following institution of the appropriate antibiotic and conservative therapy consisting of several sessions of scaling and root planning, each of these cases demonstrated a dramatic remission of disease progression. No further breakdown has been seen for a minimum of 2 1/2 years. While anecdotal in nature, these cases support the usefulness of microbial identification coupled with antibiotic sensitivity as an adjunct to conventional conservative periodontal therapy.


Assuntos
Resistência Microbiana a Medicamentos , Fluoroquinolonas , Testes de Sensibilidade Microbiana/estatística & dados numéricos , Abscesso Periodontal/microbiologia , Periodontite/microbiologia , Adulto , Aggregatibacter actinomycetemcomitans/efeitos dos fármacos , Amoxicilina/uso terapêutico , Anti-Infecciosos/uso terapêutico , Clindamicina/uso terapêutico , Humanos , Masculino , Abscesso Periodontal/tratamento farmacológico , Periodontite/tratamento farmacológico , Quinolonas/uso terapêutico , Staphylococcus aureus/efeitos dos fármacos , Resistência a Tetraciclina
10.
Clin Ther ; 12(3): 242-9, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2379229

RESUMO

The subjects were 106 patients, aged 14 to 70 years, with acute facial or oral abscesses originating from an odontogenic source. They were randomly assigned to receive 150 mg of clindamycin or 250 mg of ampicillin orally four times daily for seven days. After seven days of treatment, the infections were eradicated in 36 of the 52 clindamycin-treated patients and in 42 of the 54 ampicillin-treated patients, and improved in 16 and 11, respectively. One of the ampicillin group was a treatment failure. Mixed bacterial infections were found in most of the patients; 385 isolates were identified, 167 aerobes and 218 anaerobes. The most common aerobes were Staphylococcus aureus (in 58 patients), Staphylococcus epidermidis (in 47), and Staphylococcus viridans (in 32); the most common anaerobes were species of Peptococcus (in 76), Bacteroides (in 38), and Peptostreptococcus (in 33). No isolates were resistant to clindamycin; nine of 126 aerobes and six of 160 anaerobes were resistant to ampicillin. It is concluded that clindamycin is a safe and effective alternative antibiotic in the treatment of odontogenic infections.


Assuntos
Abscesso/tratamento farmacológico , Ampicilina/uso terapêutico , Clindamicina/uso terapêutico , Abscesso Periodontal/tratamento farmacológico , Periodontite/tratamento farmacológico , Abscesso/microbiologia , Adolescente , Adulto , Idoso , Ampicilina/efeitos adversos , Bactérias/efeitos dos fármacos , Clindamicina/efeitos adversos , Face , Humanos , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Abscesso Periodontal/microbiologia
11.
J Periodontol ; 48(4): 236-8, 1977 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-265394

RESUMO

Sensitivity tests were administered to determine the effectiveness of several antibiotics in the management of the oral abscess. Cultures were taken from 13 patients who were diagnosed as having either a periodontal or periapical abscess. Results revealed the following 1. The most effective antibiotic was Chloromycetin. Yet it was felt that its medical contraindications far outweigh its use by the dental practitioner. 2. Tetracycline was the least effective antibiotic. 3. Penicillin, because of its high potency against microorganisms of the dental abscess, should be considered the drug of choice. Its use, however, must be restricted to patients who give a negative history to allergies and/or asthma; when such a history is positive, erythromycin should be used. 4. Appropriate culture and sensitivity tests should be performed to determine the susceptibility of the causative organism(s) to the drug of choice.


Assuntos
Antibacterianos/uso terapêutico , Abscesso Periapical/tratamento farmacológico , Abscesso Periodontal/tratamento farmacológico , Periodontite/tratamento farmacológico , Adulto , Idoso , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Abscesso Periapical/microbiologia , Abscesso Periodontal/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA